CJC-1295 & Ipamorelin
Growth-hormone signaling, available evidence, FDA status and safety considerations.
Peptides are a broad class of signaling molecules and medicines—not one treatment. At our Los Angeles and Beverly Hills hormone clinic, evaluation starts with your symptoms, medical history, goals, medications and clinically appropriate testing before any peptide or hormone treatment is considered.
Book an AppointmentDavid Nazarian, M.D. • Board Certified in Internal Medicine

These guides explain what is known, what remains uncertain, regulatory considerations and when a medical or endocrine evaluation may be more appropriate.
Growth-hormone signaling, available evidence, FDA status and safety considerations.
Research context, proposed uses and the limits of current human evidence.
Evidence, risks and established alternatives for muscle and body-composition concerns.
Topical versus injectable peptides and what evidence supports for skin-related goals.
Copper peptides, route-specific evidence and injectable safety considerations.
When endocrine testing is appropriate and how true growth-hormone disorders are evaluated.
Peptides are short chains of amino acids that can act as signaling molecules. Steroid hormones have a different chemical structure and mechanism, and hormone replacement is intended to replace or treat a clinically established hormone problem. Symptoms such as fatigue, poor recovery, low libido, sleep disturbance, reduced muscle mass or weight change can have many causes.
Compare peptide therapy with HRT · Peptides vs. steroids · Hormone testing
Review symptoms, goals, medical history, medications and prior treatments.
Laboratory testing or other evaluation is selected when clinically appropriate—not as a one-size-fits-all panel.
We compare established treatments, regulatory status, evidence, uncertainties and potential risks.
When treatment is appropriate, follow-up is individualized to the therapy, diagnosis and patient response.
“Peptide therapy” is an umbrella term. Peptides include naturally occurring signaling molecules, approved peptide-based medications and experimental or unapproved compounds. The exact compound, indication, route and evidence matter.
No. Peptides and steroid hormones are chemically and biologically different classes of molecules.
Not generally. Treating a documented hormone disorder and using a compound that modifies a signaling pathway are different clinical decisions.
No. These compounds should not be presented as FDA-approved anti-aging or body-composition therapies. Their regulatory and compounding status requires careful review, and available clinical data are limited.
When symptoms could reflect an endocrine, metabolic or other medical condition, evaluation should identify the likely cause and guide treatment rather than starting with a predetermined peptide.
Yes. Our practice evaluates patients in the Los Angeles and Beverly Hills area. Recommendations depend on the individual diagnosis, evidence, safety and current regulatory considerations.
If you are considering peptide therapy, start with a medical evaluation focused on the underlying concern—not a preselected compound. We can review your symptoms, prior treatment, laboratory data and appropriate options.
Book an Appointment
David Nazarian, M.D., is Board-Certified in Internal Medicine by the American Board of Internal Medicine and has completed advanced bioidentical hormone replacement therapy training through WorldLink Medical. He provides physician-led hormone evaluation and individualized care for women and men, with an emphasis on comprehensive assessment, patient education, safety, and ongoing follow-up.
Copyright ©2026 Hormone Replacement Therapy LA. All rights reserved.